Twist Bioscience (TWST) Profit After Tax (2017 - 2026)

Twist Bioscience (TWST) has reported Profit After Tax for 10 consecutive years, with -$35.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Profit After Tax fell 272.06% year-over-year to -$35.1 million in Q2 2026; TTM through Jun 2026 was -$136.6 million, a 60.18% decrease from a year earlier, with the FY2025 full-year figure at -$77.8 million, up 62.74% from the prior year.
• Profit After Tax was -$35.1 million for Q2 2026 at Twist Bioscience, up from -$44.1 million in the prior quarter.
• Over five years, Profit After Tax peaked at $20.4 million in Q2 2025 and troughed at -$85.6 million in Q2 2024.
• A 5-year average of -$43.2 million and a median of -$43.6 million in 2022 frame the typical range for Profit After Tax.
• Across the five-year window, Profit After Tax jumped 123.82% in 2025 and tumbled 272.06% in 2026, its largest moves.
• Over 5 years, Profit After Tax stood at -$43.1 million in 2022, then gained by 0.12% to -$43.0 million in 2023, then advanced by 26.24% to -$31.7 million in 2024, then gained by 3.83% to -$30.5 million in 2025, then retreated by 15.06% to -$35.1 million in 2026.
• The last three Profit After Tax figures came in at -$35.1 million (Q2 2026), -$44.1 million (Q1 2026), and -$30.5 million (Q4 2025), per Business Quant data.